Navigation Links
Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
Date:10/21/2009

INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- More than 25 Eli Lilly and Company (NYSE: LLY) facilities around the world today will celebrate "Energy Day," which is a new corporate sustainability effort designed to educate Lilly employees about the company's latest energy reduction goals and to encourage sustainable behaviors.

Lilly reached the energy goal it previously set two years early. Over a five-year period, from 2004 to 2008, Lilly has:

  • Improved energy intensity (in energy used per dollar of sales) by more than 35 percent and reduced absolute energy use by 5.8 percent
  • Cut absolute greenhouse gas emissions by 4.4 percent

Lilly's new goal for the year 2013 is to improve energy efficiency and reduce the corresponding greenhouse gas emissions by 15 percent. In order to meet its goal, the company is pursuing energy efficiency projects and engaging employees to identify opportunities for continued improvement.

"Lilly is committed to making high-quality medicines responsibly, which includes minimizing our natural resource use and lessening our impact on the environment," said Greg Spratt, advisor of environmental sustainability at Lilly. "Our employees are eager to become more engaged and involved in protecting our environment, and we are leveraging that commitment in order to help the company meet its aggressive energy goal."

Since 2006, the company has invested $23 million in energy and waste reduction projects across the globe. Upon completion of these projects, Lilly estimates that it will save 640,000 mm BTUs of energy and reduce its greenhouse gas emissions by nearly 85,000 metric tons - the equivalent of the electricity used by 11,789 homes in one year and the amount of greenhouse gas emissions generated by burning 444 railcars of coal.

Lilly's gl
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
2. Lilly Declares Fourth-Quarter Dividend
3. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
4. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
5. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
6. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
7. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
8. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
9. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
10. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
11. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... CARLSBAD, Calif. , May 4, 2015  Isis ... an exclusive license agreement with Bayer HealthCare (Bayer) to ... of thrombosis. Under the terms of the agreement, Isis ... near-term payments, including an immediate $100 million up-front payment ... program following a Phase 2 study in patients with ...
(Date:5/4/2015)... 4, 2015 MEI Pharma, Inc. (Nasdaq: ... the clinical development of novel therapies for cancer, ... of the Company,s investigational drug candidate ME-344 in ... combined with a tyrosine-kinase inhibitor (TKI). In addition, ... a potent inhibitor of mitochondrial oxidative phosphorylation (OXPHOS) ...
(Date:5/4/2015)... of the cuvette manufacturing world, opened their doors to the public in early 2015.  ... offering scientists amazing support for their spectroscopy needs.  ... ... ... In mid-2014 Simcha Woitovich ...
Breaking Medicine Technology:Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3
(Date:5/4/2015)... 04, 2015 Malibu Biotech Systems ... breath spray. KissSafe™ is the first personal hygiene ... experience while adding fresh breath appeal. KissSafe™ contains ... kills germs in the mouth and oral cavity ... ingredients that possess additional wellness benefits. KissSafe’s proprietary ...
(Date:5/4/2015)... May 04, 2015 Milton Hershey School® ... 2015 Alumnus of the Year, recognizing his commitment to ... philanthropy he sets for MHS students. , “Dr. Graves ... happen when children are provided a top-notch education, a ... their passions,” said Pete Gurt ’85, president of MHS. ...
(Date:5/4/2015)... PROVIDENCE, R.I. (PRWEB) May 04, 2015 Johnson ... new $40 million engineering and science academic center on Wednesday, ... in the ground for land made available by the re-alignment ... at the corner of Friendship and Chestnut streets in Providence, ... being built on a parcel of land the university purchased ...
(Date:5/4/2015)... The opportunity for children to dream of a bright ... behind The Fairy Godmother Next Door, a new children’s picture ... , The inspiration for the enchanting story of a fairy ... desire to be a fairy godmother. , “My wish came ... neighbors’ children since they were born. We discuss fairies and ...
(Date:5/4/2015)... NORTH HOLLYWOOD, Calif. (PRWEB) May 04, 2015 ... awards program recognizes IPC clinical leaders who have made ... to the patients they serve, both in acute and ... Hospitalist of the Year, Post-Acute Provider of the Year, ... the Year and Specialist Provider of the Year. Recipients ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... behaviors, study says , , THURSDAY, Nov. 6 (HealthDay News) ... much lower in areas that have lots of green ... large British study finds. , Dr. Richard Mitchell, of ... previous studies have shown that the presence of green ...
... Calif., Nov. 6 Lumenis(R) Ltd. a global,developer, ... for ophthalmic, surgical and aesthetic applications,announced today that ... devices on November 8th at the American Academy ... Dov Ofer, Lumenis, President and Chief Executive Officer ...
... of veterans with posttraumatic stress disorder (PTSD) raises the ... and children in communities across the United States," says ... and an assistant professor of social work at Washington ... are very different than those for PTSD. The Department ...
... Texas, Nov. 6 The following was released ... A recent report from the U.S. Department of ... 08-01105-171) substantiated waste,mismanagement and inaction to disclosures of ... Central Texas Veterans Health,Care System (CTVHCS)., Inaction ...
... 6 Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... Officer of Savient Pharmaceuticals,will present a corporate update ... The presentation is scheduled to begin on November ... The Conference will be held at the Arizona,Biltmore ...
... 6 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), ... anti-infective products, today,announced that three patents protecting Moxatag ... Orange Book on,Oct. 24, 2008, pursuant to Section ... on Oct. 8, 2008., MiddleBrook President & ...
Cached Medicine News:Health News:Green Areas Lower Health Inequities Between Rich, Poor 2Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 2Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 4Health News:Growing problem for veterans: Domestic violence 2Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: